What is Gray Matters?
Established in 2008, Gray Matters operates at the intersection of neuroscience and clinical psychology. The company specializes in quantitative electroencephalography (qEEG) to provide precise brain mapping, which informs personalized neurofeedback protocols for patients suffering from ADHD, anxiety, and PTSD. By bridging the gap between complex neurological data and actionable therapeutic interventions, Gray Matters has established a robust footprint in the Fairfield County and Westchester County markets. Their model represents a shift toward data-driven mental health management, moving away from traditional symptomatic treatment toward objective, brain-based diagnostics.
How much funding has Gray Matters raised?
Gray Matters has raised a total of $17K across 1 funding round:
Debt
$17K
Debt (2021): $17K with participation from PPP
Key Investors in Gray Matters
PPP
Public-Private Partnership
What's next for Gray Matters?
The recent injection of capital is earmarked for the scaling of diagnostic services and the potential expansion of their clinical footprint. As the company transitions through its Series A/B growth stage, the focus will likely shift toward enhancing the technological backend of their neurofeedback platforms and potentially integrating AI-driven analytics to further refine patient outcomes. By leveraging this financing, Gray Matters aims to solidify its market position as a leader in neuro-health, potentially exploring new geographic territories or strategic partnerships with larger healthcare networks to broaden the accessibility of their specialized mental health services.
See full Gray Matters company page
